...
首页> 外文期刊>Molecular & cellular proteomics: MCP >Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC)-based Quantitative Proteomics Study of a Thyroid Hormone-regulated Secretome in Human Hepatoma Cells
【24h】

Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC)-based Quantitative Proteomics Study of a Thyroid Hormone-regulated Secretome in Human Hepatoma Cells

机译:基于细胞培养(SILAC)的人类肝癌细胞中甲状腺激素调节的分泌蛋白的定量蛋白质组学研究中的氨基酸稳定同位素标记。

获取原文
获取原文并翻译 | 示例
           

摘要

The thyroid hormone, 3, 3',5-triiodo-L-thyronine (T_3), regulates cell growth, development, differentiation, and metabolism via interactions with thyroid hormone receptors (TRs). However, the secreted proteins that are regulated by T_3 are yet to be characterized. In this study, we used the quantitative proteomic approach of stable isotope labeling with amino acids in cell culture coupled with nano-liquid chromatography-tandem MS performed on a LTQ-Orbitrap instrument to identify and characterize the T_3-regulated proteins secreted in human hepatocellular carcinoma cell lines overexpressing TRalpha1 (HepG2-TRalpha1). In total, 1742 and 1714 proteins were identified and quantified, respectively, in three independent experiments. Among these, 61 up-regulated twofold and 11 down-regulated twofold proteins were identified. Eight proteins displaying increased expression and one with decreased expression in conditioned media were validated using Western blotting. Real-time quantitative RT-PCR further disclosed induction of plasminogen activator inhibitor-1 (PAI-1), a T_3 target, in a time-course and dose-dependent manner. Serial deletions of the PAI-1 promoter region and subsequent chromatin immunoprecipitation assays revealed that the thyroid hormone response element on the promoter is localized at positions -327/-312. PAI-1 over-expression enhanced tumor growth and migration in a manner similar to what was seen when T_3 induced PAI-1 expression in J7-TRalpha1 cells, both in vitro and in vivo. An in vitro neutralizing assay further supported a crucial role of secreted PAI-1 in T_3/TR-regulated cell migration. To our knowledge, these results demonstrate for the first time that proteins involved in the urokinase plasminogen activator system, including PAI-1, uPAR, and BSSP4, are augmented in the extra- and intracellular space of T_3-treated HepG2-TRalpha1 cells. The T_3-regulated secretome generated in the current study may provide an opportunity to establish the mechanisms underlying T_3-associated tumor progression and prognosis.
机译:甲状腺激素3,3',5-三碘-L-甲状腺素(T_3)通过与甲状腺激素受体(TRs)的相互作用调节细胞的生长,发育,分化和代谢。然而,由T_3调节的分泌蛋白尚待鉴定。在这项研究中,我们使用了在细胞培养中用氨基酸稳定同位素标记的定量蛋白质组学方法,以及在LTQ-Orbitrap仪器上进行的纳米液相色谱-串联质谱联用,以鉴定和表征人类肝细胞癌中分泌的T_3调节蛋白。细胞系过表达TRalpha1(HepG2-TRalpha1)。在三个独立的实验中,总共分别鉴定和定量了1742和1714个蛋白质。其中,鉴定出61种上调两倍的蛋白质和11种下调两倍的蛋白质。使用蛋白质印迹法验证了八种在条件培养基中表达增加的蛋白质和一种在表达中减少的蛋白质。实时定量RT-PCR进一步公开了以时间过程和剂量依赖性方式诱导纤溶酶原激活物抑制剂-1(PAI-1),T_3靶标。 PAI-1启动子区域的系列删除和随后的染色质免疫沉淀试验表明,启动子上的甲状腺激素应答元件位于-327 / -312位。 PAI-1的过表达以类似于T_3在体外和体内诱导J7-TRalpha1细胞中PAI-1表达的方式增强了肿瘤的生长和迁移。体外中和测定进一步支持了分泌的PAI-1在T_3 / TR调节的细胞迁移中的关键作用。据我们所知,这些结果首次证明了尿激酶纤溶酶原激活剂系统中涉及的蛋白质,包括PAI-1,uPAR和BSSP4,在经T_3处理的HepG2-TRalpha1细胞的细胞外和细胞内空间中得到增强。当前研究中产生的T_3调节的分泌组可能为建立T_3相关肿瘤进展和预后的机制提供机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号